Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christian W Mende

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Advances in Therapy|November 30, 2021
Chronic Kidney Disease and SGLT2 Inhibitors: A Review of the Evolving Treatment LandscapeChristian W Mende
Southern Medical Journal|March 3, 2006
Improving antihypertensive therapy in patients with diabetic nephropathyChristian W Mende
Cardiovascular Drugs and Therapy|May 22, 2010
Application of direct renin inhibition to chronic kidney diseaseChristian W Mende
Current Medical Research and Opinion|December 16, 2016
Diabetes and kidney disease: the role of sodium-glucose cotransporter-2 (SGLT-2) and SGLT-2 inhibitors in modifying disease outcomesChristian W Mende
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|April 24, 2019
FATTY KIDNEY DISEASE: A NEW RENAL AND ENDOCRINE CLINICAL ENTITY? DESCRIBING THE ROLE OF THE KIDNEY IN OBESITY, METABOLIC SYNDROME, AND TYPE 2 DIABETESChristian W Mende, Daniel Einhorn
American Journal of Nephrology|January 22, 2023
Mineralocorticoid Receptor-Associated Mechanisms in Diabetic Kidney Disease and Clinical Significance of Mineralocorticoid Receptor AntagonistsChristian W Mende, Rohan Samarakoon, Paul J Higgins
Clinical Diabetes : a Publication of the American Diabetes Association|November 16, 2022
Role of Primary Care Clinicians in the Management of Patients With Type 2 Diabetes and Cardiorenal DiseasesPamela R Kushner, Matthew A Cavender, Christian W Mende
Journal of Clinical Hypertension (Greenwich, Conn.)|January 12, 2017
Efficacy of nebivolol-valsartan single-pill combination in obese and nonobese patients with hypertensionChristian W Mende, Thomas D Giles, David B Bharucha, et al.
Journal of Diabetes and Its Complications|December 19, 2021
DCRM Multispecialty Practice Recommendations for the management of diabetes, cardiorenal, and metabolic diseasesYehuda Handelsman, John E Anderson, George L Bakris, et al.
Metabolism: Clinical and Experimental|June 9, 2024
DCRM 2.0: Multispecialty practice recommendations for the management of diabetes, cardiorenal, and metabolic diseasesYehuda Handelsman, John E Anderson, George L Bakris, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Advances in Therapy|November 30, 2021
Chronic Kidney Disease and SGLT2 Inhibitors: A Review of the Evolving Treatment LandscapeChristian W Mende
Southern Medical Journal|March 3, 2006
Improving antihypertensive therapy in patients with diabetic nephropathyChristian W Mende
Cardiovascular Drugs and Therapy|May 22, 2010
Application of direct renin inhibition to chronic kidney diseaseChristian W Mende
Current Medical Research and Opinion|December 16, 2016
Diabetes and kidney disease: the role of sodium-glucose cotransporter-2 (SGLT-2) and SGLT-2 inhibitors in modifying disease outcomesChristian W Mende
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|April 24, 2019
FATTY KIDNEY DISEASE: A NEW RENAL AND ENDOCRINE CLINICAL ENTITY? DESCRIBING THE ROLE OF THE KIDNEY IN OBESITY, METABOLIC SYNDROME, AND TYPE 2 DIABETESChristian W Mende, Daniel Einhorn
American Journal of Nephrology|January 22, 2023
Mineralocorticoid Receptor-Associated Mechanisms in Diabetic Kidney Disease and Clinical Significance of Mineralocorticoid Receptor AntagonistsChristian W Mende, Rohan Samarakoon, Paul J Higgins
Clinical Diabetes : a Publication of the American Diabetes Association|November 16, 2022
Role of Primary Care Clinicians in the Management of Patients With Type 2 Diabetes and Cardiorenal DiseasesPamela R Kushner, Matthew A Cavender, Christian W Mende
Journal of Clinical Hypertension (Greenwich, Conn.)|January 12, 2017
Efficacy of nebivolol-valsartan single-pill combination in obese and nonobese patients with hypertensionChristian W Mende, Thomas D Giles, David B Bharucha, et al.
Journal of Diabetes and Its Complications|December 19, 2021
DCRM Multispecialty Practice Recommendations for the management of diabetes, cardiorenal, and metabolic diseasesYehuda Handelsman, John E Anderson, George L Bakris, et al.
Metabolism: Clinical and Experimental|June 9, 2024
DCRM 2.0: Multispecialty practice recommendations for the management of diabetes, cardiorenal, and metabolic diseasesYehuda Handelsman, John E Anderson, George L Bakris, et al.
Pageof 1